Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response

Hyun Young Woo, Jun Yong Park, Si Hyun Bae, Chang Wook Kim, Jae Young Jang, Won Young Tak, Dong Joon Kim, In Hee Kim, Jeong Heo, Sang Hoon Ahn

Clin Mol Hepatol. 2020;26(3):352-363. Published online May 28, 2020

DOI: https://doi.org/10.3350/cmh.2019.0044n

View: 5462 Download: 192 Web of Science: 6 Crossref: 8

Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B

Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh

Clin Mol Hepatol. 2017;23(4):331-339. Published online September 26, 2017

DOI: https://doi.org/10.3350/cmh.2016.0040

View: 8670 Download: 223 Web of Science: 14 Crossref: 10

Editorial

Lamivudine: fading into the mists of time

Jonggi Choi, Young-Suk Lim

Clin Mol Hepatol. 2017;23(4):314-315. Published online November 28, 2017

DOI: https://doi.org/10.3350/cmh.2017.0110

View: 6053 Download: 124

Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?

Joon Yeul Nam, Jeong-Hoon Lee

Clin Mol Hepatol. 2017;23(4):311-313. Published online December 4, 2017

DOI: https://doi.org/10.3350/cmh.2017.0069

View: 6462 Download: 145

Original Article

Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir

Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin

Clin Mol Hepatol. 2017;23(3):230-238. Published online June 30, 2017

DOI: https://doi.org/10.3350/cmh.2017.0003

View: 10046 Download: 166 Web of Science: 12 Crossref: 14

Editorial

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

Byung-Cheol Song

Clin Mol Hepatol. 2016;22(4):439-442. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0108

View: 7985 Download: 111 Web of Science: 1 Crossref: 1

Original Article

The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy

Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon

Clin Mol Hepatol. 2016;22(2):241-249. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2015.0053

View: 10302 Download: 139 Web of Science: 4 Crossref: 4

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B

Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park

Clin Mol Hepatol. 2016;22(1):152-159. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.152

View: 9820 Download: 95

Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy

Jung Gil Park, Soo Young Park

Clin Mol Hepatol. 2015;21(3):242-248. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.242

View: 8622 Download: 87 Web of Science: 5 Crossref: 4

Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients

Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim

Clin Mol Hepatol. 2015;21(2):131-140. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.131

View: 8425 Download: 85 Web of Science: 2 Crossref: 2

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients

Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa

Clin Mol Hepatol. 2015;21(1):41-48. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.41

View: 8939 Download: 85 Web of Science: 14 Crossref: 11

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B

Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2014;20(3):274-282. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.274

View: 7099 Download: 44 Web of Science: 3 Crossref: 2

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir

EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee

Clin Mol Hepatol. 2014;20(3):267-273. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.267

View: 8319 Download: 72 Web of Science: 4 Crossref: 5

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Dong Jin Suh, Seung Woon Paik, Kwang Hyub Han, Soon Ho Um, Byung Ik Kim, Heon Ju Lee, Mong Cho, Chun Kyon Lee, Dong Joon Kim, Jae Seok Hwang

Clin Mol Hepatol. 2014;20(2):168-176. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.168

View: 8657 Download: 64 Web of Science: 4 Crossref: 2

HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data

Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2013;19(4):409-416. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.409

View: 6646 Download: 62 Crossref: 6

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients

Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2013;19(3):273-279. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.273

View: 6785 Download: 42 Crossref: 1

Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients

Young Kul Jung, Jong Eun Yeon, Kwang Gyun Lee, Eun Seok Jung, Jeong Han Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Sun Ho Um, Ho Sang Ryu, Kwan Soo Byun

Clin Mol Hepatol. 2011;17(4):261-267. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.261

View: 6854 Download: 50 Crossref: 10

Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study

George KK Lau, Nancy Leung

Clin Mol Hepatol. 2010;16(3):315-320. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.315

View: 7374 Download: 40 Crossref: 10

3

Efficacy of 48-week clevudine therapy for chronic hepatitis B

Min Hwan Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D., Hyun Woong Lee, M.D. Hyung Joon Kim, M.D. Sang Gu Yun, M.D., Nam-Hoon Kim, M.D., Won Ki Bae, M.D., Young Soo Moon, M.D.

Clin Mol Hepatol. 2009;15(3):331-337. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.331

View: 5054 Download: 23 Crossref: 8

Long-term clevudine therapy in nucleos(t)ide-naive and Lamivudine-experienced patients with hepatitis B virus-related chronic Liver diseases

Heon Ju Lee, M.D., Jong Ryul Eun, M.D., Chang Hyeong Lee, M.D. Jae Seok Hwang, M.D. Jeong Ill Suh, M.D. Byung Seok Kim, M.D. Byoung Kuk Jang, M.D. Departments of

Clin Mol Hepatol. 2009;15(2):179-192. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.179

View: 5851 Download: 32 Crossref: 12

Comparison of Lamivudine-induced HBsAg Loss rate according to age in children with chronic hepatitis B

Jung Mi Kim , Byung Ho Choe , Mi Ae Chu , Seung Man Cho

Clin Mol Hepatol. 2009;15(2):168-178. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.168

View: 4660 Download: 47 Crossref: 4

Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, Lamivudine-resistant chronic hepatitis B patients

Hyun Wook Jung , Moon Seok Choi , Kap Hyun Kim , Sung Hyun Park , Keum Yeon Kwak , Joon Hyoek Lee , Kwang Cheol Koh , Seung Woon Paik , Byung Chul Yoo

Clin Mol Hepatol. 2009;15(1):52-58. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.52

View: 4801 Download: 21

4

A case report of treatment with pegylated interferon alpha for Lamivudine-resistant chronic hepatitis B virus infection

Won Haing Hur , Hyun Young Woo , Soung Won Jeong , Chan Ran You , Si Hyun Bae , Jong Young Choi , Seung Kew Yoon

Clin Mol Hepatol. 2008;14(4):513-518. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.513

View: 4896 Download: 32 Crossref: 1

3

The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with Lamivudine-resistant chronic hepatitis B infection

Jae Hyeon Moon , Mong Cho , Ki Tae Yoon , Jung Ho Bae , Jeong Heo , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song

Clin Mol Hepatol. 2008;14(4):503-512. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.503

View: 4414 Download: 16 Crossref: 2

7

The Korean Journal of Entecavir 1 mg therapy for Lamivudine-refractory chronic hepatitis B

Hyung Joon Kim

Clin Mol Hepatol. 2008;14(3):411-416. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.411

View: 4323 Download: 20

The Korean Journal of Adefovir plus Lamivudine combination therapy in Lamivudine-resistant chronic hepatitis B

So Young Kwon

Clin Mol Hepatol. 2008;14(2):235-239. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.235

View: 3814 Download: 20

3

Hepatitis B core antigen expression pattern predicts response to Lamivudine therapy in patients with chronic hepatitis B

Kyeh Dong Shi, M.D., Seong Gyu Hwang, M.D., Ju Hyun Choi, M.D., Il Joon Hwang, M.D., Jai Ho Yoon, M.D., Kwang Il Kim, M.D. Chang-Il Kwon, M.D., Sung Pyo Hong, M.D., Pil Won Park, M.D., Kyu Sung Rim, M.D.

Clin Mol Hepatol. 2008;14(2):197-205. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.197

View: 4849 Download: 24 Crossref: 3

Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients

Jin Hee Cho, M.D., Jae Youn Cheong, M.D., Joon Koo Kang, M.D., Jin Sun Park, M.D., Myoung Hee Lee, M.D., Nam Kyu Lim, M.D., Sun Pyo Hong. Soo-Ok Kim. Wang Don Yoo. and Sung Won Cho, M.D.

Clin Mol Hepatol. 2008;14(1):58-66. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.58

View: 4707 Download: 22 Crossref: 1

Change of HBV DNA Level as a Predictor of HBeAg Loss after Lamivudine Treatment

Jae Kwon Jung, M.D., Chang Hyeong Lee, M.D., Eun Young Kim, M.D., Jin Tae Jung, M.D., Joon Hyuck Choi, M.D., Ji Min Han, M.D., Myoung In Jin, M.D., Ju Yeon Cho, M.D., Byung Seok Kim, M.D., Im Hee Shin, Ph.D.

Clin Mol Hepatol. 2007;13(4):513-520. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.513

View: 3843 Download: 28

Effect of Initial Virologic Response to Adefovir on the Development of Resistance to Adefovir in Lamivudine-resistant Chronic Hepatitis B

In Hee Kim , Seong Hun Kim , Hyun Chul Kim , Kyoung Deok Shin , Sang Wook Kim , Seong Ok Lee , Soo Teik Lee , Dae Ghon Kim

Clin Mol Hepatol. 2007;13(3):349-362. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.349

View: 4317 Download: 18 Crossref: 1

1 | 2 | 3 |

Viewed By 5055	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4978	MAFLD: How is it different from NAFLD?
Viewed By 4445	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4398	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4322	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 248	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 198	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 137	MAFLD: How is it different from NAFLD?
Cited By 113	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search